BNET Industries

Market Cap:$149.2B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Roche's Merger Formula for Genentech
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
-
FDA panel backs Pfizer's anti-infection vaccine for kids
-
Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started
-
Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China
News & Analysis
Filter by
pfizer inc. and united technologies corp. - All News and Analysis
Year to Date Performance of Dow 30 Members
Hickey and Walters Bespoke submit: Below we highlight the year to date performance of the 30 DJIA members with four months remaining in 2008. As shown, Wal-Mart WMT tops the list with a gain of 27.5% year to date. WMT is trailed by IBM (14%), McDonald's (8.2%), Johnson&Johnson...
Dow Price Targets from Last November
Hickey and Walters Bespoke submit: Barry Ritholtz over at the Big Picture recently highlighted Bloomberg's Chart of the Day showing that analyst profit forecasts are currently worse than ever. With that in mind, we pulled up a post we did back in November highlighting the average analyst price...
Dow 30 Trading Ranges
Below we highlight the 30 Dow members with respect to their various trading ranges. After the recent volatility in the markets (S&P 500 +2.9% on Tuesday, -1.8% yesterday) some of these stocks are on the move. BAC had traded at its theoretical high of $34 and has declined over the...
The stock market's reaction to changes in the federal funds target rate
ABSTRACT This paper examines the stock price reaction of individual stocks listed in the Dow Jones Industrial Average DJIA to Federal Funds target rate change announcements using daily stock returns over the period from January 2, 1996 to May 25, 2007. We measure such reactions using an event-study methodology...
Schaeffer's Midday Options Update Features Google, General Electric, United Technologies, Fortune Brands, Pfizer
CINCINNATI -- Today's Schaeffer's Midday Options Update Features Google (NASDAQ:GOOG), General Electric (NYSE:GE), United Technologies (NYSE:UTX), Fortune Brands (NYSE:FO), Pfizer (NYSE:PFE). The Midday Options Update contains a brief commentary on the day's most notable activity and a table listing the most active calls and puts for the day. The Midday...
Schaeffer's S&P 500 Index Hot Stocks Features Nike, Fiserv, United Technologies, Pfizer and Leggett & Platt
CINCINNATI -- Among the stocks featured in the December 17 edition of Schaeffer's S&P 500 Index Hot Stocks are Nike (NYSE:NKE), Fiserv (NASDAQ:FISV), United Technologies (NYSE:UTX), Pfizer (NYSE:PFE), and Leggett & Platt (NYSE:LEG). Schaeffer's S&P 500 Index Hot Stocks is just one of the many free market commentaries written everyday...
Industrial Research Institute's 6th annual R&D leaderboard: R&D spending by the top 100 U.S. and global technology investors in 2003
Neither IRI's nor other industry sages' predictions or early estimates for R&D spending in 2003 foresaw the robust turnaround in R&D that actually occurred. Spending in 2003 by the top 100 U.S. companies increased from 2002 by 5.4 percent to $120 billion (Table 1). In retrospect, with better data now...
Industrial Research Institute's 5th Annual R&D Leaderboard: R&D spending by the top 100 U.S./global technology investors in 2002
When the Industrial Research Institute predicted early last year that U.S. companies would be cutting their R&D spending, it was a distinctly minority opinion, made with trepidation (1). But the weak signals turned out to be accurate and--for the first time in more than 10 years--R&D investment by the top...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes


